European Shoppers Hunt for Bargains Amid Rising Economic and Political Pessimism
BCG's Survey of Over 16,000 European Consumers Finds 54% Are Pessimistic About Their Country's Economy and 52% Worry Daily About Their Personal Finances
Consumers Cut Back on Discretionary Spending; Expect to Increase Spending on Two Fronts: Essentials and Luxury
Online Shopping, Sustainability, and Deal-Seeking Reshape Consumer Preferences and Expectations
BOSTON, June 10, 2025 /PRNewswire/ -- European consumers are navigating 2025 with growing unease, reevaluating their spending priorities due to economic, political, and environmental concerns. According to a new report by Boston Consulting Group (BCG), more than half (54%) of surveyed European consumers are pessimistic about the economy in their home country—a 7 point increase since July 2024. Meanwhile, 52% worry daily about their personal finances—a 9 point increase from last year.
These findings are part of BCG's latest European Consumer Sentiment Report, titled European Consumers Brace for More Uncertainty, based on an April survey of over 16,000 consumers across nine countries. The study reveals a widespread shift toward financial caution and value-driven spending.
In addition to economic unease, political anxieties run high, with 57% of Europeans expressing pessimism. But anxiety isn't felt equally: over 73% of consumers in France, 71% in Romania, and 70% in Spain feel pessimistic, compared with just 38% in Scandinavia. The impact of tariffs remains a lesser concern, cited by only 30% of consumers—lower than the 42% of consumers concerned about sustainability and climate change.
"Across Europe, consumers are becoming more selective and deal-driven," said Andreas Malby, leader of BCG's Consumer practice in Europe, the Middle East, Africa, and South America, and a coauthor of the report. "With consumers scrutinizing every purchase, brands are now competing on trust, ethics, and value for money."
The Hunt for Deals Intensifies
Good value for money is the most important purchasing factor in all nine countries surveyed; cited by 59% of consumers. The ability to save and low prices ranked second and third; cited by 48% and 47% of shoppers, respectively.
Consumers are cutting back on discretionary items such as apparel (-22% net spending), alcohol (-18%), and snacks (-15%). Spending on household essentials, however, has risen, driven largely by inflation rather than volume.
Luxury fashion is bucking the downward trend. High-income consumers and luxury buyers plan to increase spending in this category in the next six months.
What Consumers Are Looking For
As consumers weather economic uncertainty, they're adjusting their spending priorities and expectations:
Physical Stores Aren't Disappearing Just Yet. Compared with 2024, consumers report a modest drop in online shopping as they curb spending on discretionary items. Nearly three-quarters (72%) of consumers deem physical stores essential, indicating a preference toward integrated shopping experiences across channels.
Two-day Delivery Is Becoming the Expectation. For categories such as groceries and alcohol, 83% and 71% of consumers expect two-day delivery respectively. Scandinavian consumers, however, are more likely to have lower expectations for delivery speed compared with other European markets.
Amid Sustainability Concerns, Consumers Buy Second Hand. Nearly half (45%) consider sustainability when shopping (up 5 percentage points), but only 17% are willing to pay a premium. More consumers are turning to secondhand shopping in response to sustainability concerns. Approximately 20% of European consumers regularly buy apparel, toys, luxury fashion, and furniture second hand. Rates are notably higher in Scandinavia (25% to 35%) than in Spain and Italy (10% to 15%).
Before Buying, Consumers Weigh Ethical Implications. More than one-third of consumers say they boycott brands for ethical or political reasons, up 6 percentage points from last year. This shift signals that brands must appeal not only to consumers' wallets, but to their values.
"This is a defining moment for consumer companies," Malby said. "Brands should make bold portfolio and pricing decisions while planting seeds for the future. Although the current climate is challenging, growth will return—companies should manage for both today and a brighter tomorrow."
Download the publication here:https://www.bcg.com/publications/2025/europeans-brace-for-more-uncertainty
Country-level insights are available for Denmark, France, Germany, Italy, Norway, Romania, Spain, Sweden, and the UK.
Media Contact:Eric Gregoire+1 617 850 3783gregoire.eric@bcg.com
About Boston Consulting GroupBoston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG was the pioneer in business strategy when it was founded in 1963. Today, we work closely with clients to embrace a transformational approach aimed at benefiting all stakeholders—empowering organizations to grow, build sustainable competitive advantage, and drive positive societal impact.
Our diverse, global teams bring deep industry and functional expertise and a range of perspectives that question the status quo and spark change. BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures. We work in a uniquely collaborative model across the firm and throughout all levels of the client organization, fueled by the goal of helping our clients thrive and enabling them to make the world a better place.
View original content to download multimedia:https://www.prnewswire.com/news-releases/european-shoppers-hunt-for-bargains-amid-rising-economic-and-political-pessimism-302477049.html
SOURCE Boston Consulting Group (BCG)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
New IBO Survey Reveals Major Cuts to Lab Budgets Amid NIH Grant Terminations
ARLINGTON, Va., June 10, 2025 /PRNewswire/ -- A new survey conducted by Instrument Business Outlook (IBO) has uncovered significant reductions in laboratory budgets across the U.S. academic and government research landscape, with lab product spending sharply impacted by recent NIH grant terminations. The findings, based on an exclusive IBO survey, shed light on the growing financial uncertainty facing scientific research labs in 2025. The results follow widespread disruptions in NIH funding, with more than 1,500 grants totaling $7.5 billion terminated as of May 20, according to data from Grant Watch. While the exact numbers remain fluid due to inconsistent reporting by federal agencies, the toll is undeniable: R01 research grants—a cornerstone of basic research—have been particularly hard-hit, with 322 grants worth nearly $790 million terminated. "The fallout from NIH funding changes is cascading through the research ecosystem," said Tanya Samazan, Editor-In-Chief. "Our survey shows just how deeply this uncertainty is affecting labs—from basic research to clinical trial infrastructure." Survey Highlights: Budget Cuts Across the Board Conducted by the Science Advisory Board (SAB) between mid- and late May, the survey collected 117 responses from U.S.-based labs, with 88 indicating their labs were impacted by NIH-related funding disruptions. Key findings include: 59% of labs report direct impacts from NIH-related grant or contract terminations, delays, or reductions. 47% report indirect impacts. Among affected labs, nearly 60% have reduced 2025 operating budgets by more than 10%. 51% report capital budget reductions exceeding 10%. When excluding labs that were uncertain or unaffected, the scale becomes even more dramatic: 71% of labs report operating budget cuts of over 10%. 71% report similar reductions in capital budgets. Lab Tools and Consumables Hit Hardest Every category of lab spending has been affected, according to survey data: 80% of labs have reduced their 2025 consumables budgets, making it the most impacted category. 63% have cut software/informatics budgets. 70% have reduced spending on devices under $50,000. Even high-end instrumentation (>$150,000) hasn't been spared, with 62% of labs trimming these budgets. Institutes Most Affected The survey findings align with NIH grant termination data indicating the hardest-hit institutions include: National Institute of Mental Health, with over $400 million in losses. National Institute of General Medical Sciences, which lost the highest number of grants (134). Institutes heavily reliant on lab instruments, including the National Institute of Biomedical Imaging and Bioengineering and the National Human Genome Research Institute. Medical schools and hospitals have borne a significant share of the burden, accounting for 50% of terminated grants and 55% of total terminated NIH dollars. A Shifting Landscape with No Clear Path Forward The rapidly evolving nature of NIH decisions—including ongoing terminations and reinstatements—has created a volatile funding environment. Labs are being forced to make difficult decisions with limited visibility into future funding. About Instrument Business Outlook (IBO)IBO is a leading newsletter providing market intelligence for the analytical instrument industry. Published by Strategic Directions International (SDi), a division of Science and Medicine Group, IBO offers in-depth coverage of technology, business, and market trends affecting the life sciences and lab tools sectors. View original content to download multimedia: SOURCE Instrument Business Outlook


Eater
16 minutes ago
- Eater
Heritage, The Ukrainian Village Restaurant That Redefined Caviar Service, Will Close
During Heritage Restaurant & Caviar Bar's eight years in Ukrainian Village, Chef Guy and Tif Meikle have witnessed how perceptions of dissolved for an item once thought reserved for only the rich and famous. Heritage was part of the rise of the unstuffy caviar bar. Tif Meikle says part of that was attributed to the neighborhood. Many with Eastern European roots don't have the same apprehensions about enjoying sturgeon eggs. The restaurant spread that ethos and became a welcoming bar and restaurant that not only embraced the Meikles' backgrounds, but also the backgrounds of its staff. The restaurant weathered a fire and that pandemic, each time returning and reinventing itself, rewriting the love letter to Chicago that Guy Meikle hoped Heritage would fulfill. 'It started out wanting to honor my family and Tif's family — all those that came before us,' Guy Meikle says. 'We started throwing all of our staff's memories into it, their identities… we eventually became such a safe haven for everyone.' Heritage's story at 2700 W. Chicago Avenue is about to end. The Miekles announced they'll close their restaurant on Saturday, August 30. The Miekles praised their landlord, but say they couldn't afford the proposed lease increases: 'Do I have the stomach for it?' Guy Miekle asks. 'We just kind of looked at it and felt it was time.' Fighting back tears, Tif Meikle says they're hopeful to have a great summer, but their priority is to enable their 30 or so workers to use Heritage as a springboard to find new jobs. The restaurant will host its regular slate of summer events, including an August 1 block party and a Father's Day lamb roast. Additionally, its basement remains ready to host private parties. Making caviar 'approachable and fun' is something Tiffany Miekle is proud of, and something 'we didn't think could happen in our lives.' The Mielkes showcased paczkyi and other popular European staples that Chicagoans cherish. But they would invite other cultures to the party, too. The menu includes ramen, Korean fried chicken nuggets, and more. Through eight years, Guy Miekle says he and his wife have tried to treat staff the right way, and wish more restaurants did the same. The couple hopes the next tenant who occupies the space enjoys success. 'I still think it's the best job that you possibly can have, I have loved having my own business,' he says. Heritage Restaurant & Caviar Bar , 2700 W. Chicago Avenue, closing on Saturday, August 30 Heritage Restaurant & Caviar Bar See More: Chicago Restaurant Closings
Yahoo
20 minutes ago
- Yahoo
Novo Nordisk to present array of new portfolio data including studies with semaglutide and CagriSema, expanding evidence in obesity and diabetes care at ADA 2025
Full data of Phase 3 REDEFINE 1 and 2 trial results will provide insights on the potential of CagriSema Semaglutide real-world data complements evidence from previous cardiometabolic and kidney outcomes trials Data on pipeline candidate amycretin to underscore Novo Nordisk's scientific efforts to continued innovation in obesity PLAINSBORO, N.J., June 10, 2025 /PRNewswire/ -- Novo Nordisk today announced that new data from its industry-leading cardiometabolic portfolio will be showcased at the upcoming American Diabetes Association (ADA) 85th Scientific Sessions taking place in Chicago, June 20 – 23, 2025. A total of 29 abstracts will be presented, including trials investigating the efficacy and safety of CagriSema in people with overweight/obesity (REDEFINE 1) and those with overweight/obesity and type 2 diabetes (REDEFINE 2).1 Further, new data will complement the extensive body of cardiometabolic and kidney evidence for semaglutide in people with type 2 diabetes through analyses of the SOUL, STRIDE and FLOW trials, as well as insights from additional real-world studies in adults with obesity.2-4 "We recognize the complex interplay between cardiovascular and metabolic diseases, including type 2 diabetes and obesity, which require a personalized treatment approach," said Martin Holst Lange, Executive Vice President for Development at Novo Nordisk. "As we look to build an impactful portfolio of medicines to address patient needs, our data presented at ADA 2025 demonstrates not only how we are already delivering for a wide range of these needs with semaglutide, but that we are continuing to invest in innovation to support people living with serious chronic disease." The presentation of the CagriSema REDEFINE 1 and 2 trials are the first ever Phase 3 data presented on a GLP-1 and amylin receptor agonist combination, offering insights into the potential of this investigational medicine. Data will also be presented on pipeline candidate amycretin, demonstrating Novo Nordisk's scientific efforts to deliver innovation in cardiometabolic diseases and individualized healthcare solutions.1 On June 22nd, Novo Nordisk will also host an R&D investor event on our metabolic and cardiovascular health portfolio to cover the science and abstracts presented at the congress. The event will be accessible via a live webcast on the Novo Nordisk investor website. Full details of Novo Nordisk abstracts to be presented at ADA 2025. These data for medicines containing semaglutide, CagriSema, amycretin, insulin icodec, and IcoSema are investigational: ADA Scientific Sessions: